Home
>
US Stocks
>
Gemini Therapeutics Inc
Gemini Therapeutics Inc
GMTX

Gemini Therapeutics Inc (GMTX)

$3.521.95%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
3.62
Today Low/High
3.5 / 3.62
52 Week Low/High
$3.4 / $19.09
Market Cap
$152.61M

Company Details

Gemini Therapeutics is a clinical stage precision medicine company developing novel therapeutic compounds to treat genetically de?ned age-related macular degeneration (AMD). Gemini's lead candidate, GEM103, is a recombinant form of the human complement factor H protein (CFH), and is designed to address both complement hyperactivity and restore retinal health in patients with AMD. GEM103 is currently in a Phase 2a trial in dry AMD patients with a CFH risk variant. The company has generated a rich pipeline including recombinant proteins, gene therapies, and monoclonal antibodies.
Organisation
Gemini Therapeutics Inc
Employees
29

Discover more

Frequently Asked Questions

What is Gemini Therapeutics Inc (GMTX) share price today?

Can Indians buy Gemini Therapeutics Inc (GMTX) shares?

How can I buy Gemini Therapeutics Inc (GMTX) shares from India?

Can Fractional shares of Gemini Therapeutics Inc (GMTX) be purchased?

What are the documents required to start investing in Gemini Therapeutics Inc (GMTX) stocks?

We are a SEBI registered investement advisor